Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study
We identified 8540 patients with rheumatic and musculoskeletal diseases who were diagnosed with COVID-19. Risk of hospitalisation was lower in the late cohort than in the early cohort. The risks of severe outcomes have improved over time but remain substantial.
